The Course of Incipient and Overt Diabetic Nephropathy: The Perspective of More Optimal Insulin Treatment

  • Bo Feldt-Rasmussen

Abstract

The long-term objective of insulin treatment of insulin dependent diabetes mellitus (IDDM) is prevention of late complications. Through the years it has been a widely accepted hypothesis that development of such microvascular complications should be, at least in part, due to the lack of good glycaemic control. This hypothesis has been unduely hard to prove but results from a number of small scaled intervention studies and the result of the larger scaled American Diabetes Control and Complication Trial (DCCT) has now decisively documented, that development and progression of diabetic complications is closely associated with poor glycaemic control. The design and outcome of a number of these studies will be presented and discussed in this chapter as will the practical consequences of this newly gained knowledge.

Keywords

Glycaemic Control Insulin Infusion Continuous Subcutaneous Insulin Infusion Urinary Albumin Excretion Rate Insulin Dependent Diabetes Mellitus Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosenstock J, Raskin P. Early diabetic nephropathy: Assessment and potential therapeutic interventions. Diabetes Care 1986; 9: 529–545.PubMedCrossRefGoogle Scholar
  2. 2.
    Symposium on diabetic nephropathy. Kidney Int 1992; 41: 717–929.CrossRefGoogle Scholar
  3. 3.
    Feldt-Rasmussen B. Microalbuminuria and clinical nephropathy in Type 1 (insulin-dependent) diabetes mellitus: Pathophysiological mechanisms and intervention studies (Thesis). Dan Med Bull 1989; 36: 405–415.PubMedGoogle Scholar
  4. 4.
    Jensen T. Albuminuria — a marker of renal and general vascular disease in IDDM (Thesis). Dan Med Bull 1991; 38: 134–144.PubMedGoogle Scholar
  5. 5.
    Mathiesen ER. Prevention of diabetic nephropathy: Microalbuminuria and perspectives for intervention in insulin-dependent diabetes (Thesis). Dan Med Bull 1993; 40: 273–285.PubMedGoogle Scholar
  6. 6.
    Christensen CK. The pre-proteinuric phase of diabetic nephropathy (Thesis). Dan Med Bull 1991; 38: 145–159.PubMedGoogle Scholar
  7. 7.
    Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC. Microalbuminuria: An early marker of renal involvement in diabetes. Uremia Invest 1986; 9: 85–95.Google Scholar
  8. 8.
    Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of Type 1 diabetes. Lancet 1993; 341: 1306–1309.PubMedCrossRefGoogle Scholar
  9. 9.
    Hanssen KF, Dahl-Jørgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T. Diabetic control and microvascular complications: The near-normoglycaemic experience. Diabetologia 1986; 29: 677–684.PubMedCrossRefGoogle Scholar
  10. 10.
    Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Steno Study Group. Two years experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985; 34: suppl. 3: 74–79.PubMedCrossRefGoogle Scholar
  11. 11.
    Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of 2 years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986; 1: 1300–1304.CrossRefGoogle Scholar
  12. 12.
    Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T. Effect of improved metabolic control on loss of kidney function in insulin-dependent diabetic patients. Diabetologia 1991; 34: 164–170.PubMedCrossRefGoogle Scholar
  13. 13.
    Dahl-Jørgensen K, Hanssen KF, Kierulf P, Bjøro T, Sandvik L, Aagenaess Ø. Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 1988; 117: 19–25.Google Scholar
  14. 14.
    Dahl-Jørgensen K, Bjøro T, Kierulf P, Sandvik L, Bangstad HJ, Hanssen KF. The effect of long-term strict glycaemic control on kidney function in insulin-dependent diabetes mellitus: seven years result from the Oslo Study. Kidney Int 1992; 41; 920–923.PubMedCrossRefGoogle Scholar
  15. 15.
    Reichard P, Berglund B, Britz A, Cars I, Nilsson BY, Rosenqvist U. Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM). The Stockholm Diabetes Intervention Study after five years. J Intern Med 1991; 230: 101–108.PubMedCrossRefGoogle Scholar
  16. 16.
    Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304–309.PubMedCrossRefGoogle Scholar
  17. 17.
    The Diabetes Control an Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Bo Feldt-Rasmussen

There are no affiliations available

Personalised recommendations